β受体阻滞剂-话题@MedSci

#β受体阻滞剂#

106篇内容 | 3925人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1274937, encodeId=3ef912e493784, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Sci Rep：终末期肾脏疾病患者可应用β受体阻滞剂预防房颤发生, objectType=article, longId=61258, objectId=b2b761258d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2b761258d2, replyNumber=0, likeNumber=50, createdTime=2015-12-30, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2b761258d2, moduleTitle=Sci Rep：终末期肾脏疾病患者可应用β受体阻滞剂预防房颤发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2b761258d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274936, encodeId=cfd412e4936e5, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Thorax：长效β受体阻滞剂与长效毒蕈碱受体拮抗剂联合治疗COPD的疗效与安全分析, objectType=article, longId=58515, objectId=c3125851569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3125851569, replyNumber=0, likeNumber=66, createdTime=2015-11-10, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3125851569, moduleTitle=Thorax：长效β受体阻滞剂与长效毒蕈碱受体拮抗剂联合治疗COPD的疗效与安全分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3125851569)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274935, encodeId=8aea12e4935e1, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=心衰伴房颤患者，β受体阻滞剂仍是治疗的“基石”吗？, objectType=article, longId=58273, objectId=c697582e312, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c697582e312, replyNumber=0, likeNumber=93, createdTime=2015-11-05, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c697582e312, moduleTitle=心衰伴房颤患者，β受体阻滞剂仍是治疗的“基石”吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c697582e312)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274934, encodeId=a6d212e49349d, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=非心脏手术患者的高血压治疗无需β受体阻滞剂？, objectType=article, longId=57289, objectId=730f5e289eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=730f5e289eb, replyNumber=0, likeNumber=76, createdTime=2015-10-17, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=730f5e289eb, moduleTitle=非心脏手术患者的高血压治疗无需β受体阻滞剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=730f5e289eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274933, encodeId=295812e493352, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JAMA Intern Med：使用β受体阻滞剂降压治疗风险大, objectType=article, longId=57029, objectId=deca5e0298e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deca5e0298e, replyNumber=0, likeNumber=83, createdTime=2015-10-11, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deca5e0298e, moduleTitle=JAMA Intern Med：使用β受体阻滞剂降压治疗风险大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=deca5e0298e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274932, encodeId=1d3512e493214, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JACC：急性心肌梗死后β受体阻滞剂的剂量对生存率的影响, objectType=article, longId=56459, objectId=e57356459ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e57356459ae, replyNumber=0, likeNumber=51, createdTime=2015-09-24, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e57356459ae, moduleTitle=JACC：急性心肌梗死后β受体阻滞剂的剂量对生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e57356459ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274931, encodeId=560712e4931c7, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=BMJ:β受体阻滞剂可减少COPD的急性发作, objectType=article, longId=55494, objectId=b3d655494a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3d655494a6, replyNumber=0, likeNumber=66, createdTime=2015-08-30, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3d655494a6, moduleTitle=BMJ:β受体阻滞剂可减少COPD的急性发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3d655494a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274930, encodeId=405912e49302a, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=World J Surg：闭合性创伤性脑损伤后，β受体阻滞剂对生存率的影响, objectType=article, longId=54975, objectId=02df549e5eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02df549e5eb, replyNumber=0, likeNumber=66, createdTime=2015-08-19, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02df549e5eb, moduleTitle=World J Surg：闭合性创伤性脑损伤后，β受体阻滞剂对生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02df549e5eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274929, encodeId=8f5212e492912, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JACC Heart Fail：急性失代偿性心衰(ADHF)患者β受体阻滞剂治疗不能停, objectType=article, longId=54663, objectId=85c85466365, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85c85466365, replyNumber=0, likeNumber=72, createdTime=2015-08-12, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85c85466365, moduleTitle=JACC Heart Fail：急性失代偿性心衰(ADHF)患者β受体阻滞剂治疗不能停, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85c85466365)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274928, encodeId=ad8112e492857, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Circulation：冠脉搭桥手术后的病人长期服用β受体阻滞剂有无必要？, objectType=article, longId=50920, objectId=d64a50920ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d64a50920ad, replyNumber=0, likeNumber=31, createdTime=2015-05-20, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d64a50920ad, moduleTitle=Circulation：冠脉搭桥手术后的病人长期服用β受体阻滞剂有无必要？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d64a50920ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274927, encodeId=6e3312e4927d1, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=SC-ICC2015：孙宁玲--β受体阻滞剂可作为高血压一线治疗药物吗？, objectType=article, longId=49414, objectId=79a64941446, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79a64941446, replyNumber=0, likeNumber=84, createdTime=2015-04-17, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79a64941446, moduleTitle=SC-ICC2015：孙宁玲--β受体阻滞剂可作为高血压一线治疗药物吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79a64941446)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274926, encodeId=e9f512e4926ce, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=CCQO：β受体阻滞剂对冠心病患者没有明显临床疗效, objectType=article, longId=41026, objectId=d9824102628, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9824102628, replyNumber=0, likeNumber=63, createdTime=2014-10-11, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9824102628, moduleTitle=CCQO：β受体阻滞剂对冠心病患者没有明显临床疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9824102628)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274925, encodeId=3ce412e492565, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=郭艺芳：β受体阻滞剂不会走下神坛, objectType=article, longId=37838, objectId=821e3e838ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=821e3e838ef, replyNumber=0, likeNumber=61, createdTime=2014-07-17, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=821e3e838ef, moduleTitle=郭艺芳：β受体阻滞剂不会走下神坛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=821e3e838ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274924, encodeId=df3c12e492421, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JAMA Inter Med：研究质疑心脏搭桥手术前使用β受体阻滞剂的作用, objectType=article, longId=36573, objectId=5ddf365e3ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ddf365e3ff, replyNumber=0, likeNumber=87, createdTime=2014-06-19, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ddf365e3ff, moduleTitle=JAMA Inter Med：研究质疑心脏搭桥手术前使用β受体阻滞剂的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ddf365e3ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274923, encodeId=bad912e49238a, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Gastroenterology：非选择性β受体阻滞剂可能增加自发性细菌性腹膜炎的肝硬化患者的死亡风险, objectType=article, longId=36147, objectId=74c73614e97, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74c73614e97, replyNumber=0, likeNumber=80, createdTime=2014-06-10, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74c73614e97, moduleTitle=Gastroenterology：非选择性β受体阻滞剂可能增加自发性细菌性腹膜炎的肝硬化患者的死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74c73614e97)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274922, encodeId=260012e4922b1, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Lancet：欧洲心脏病学会β受体阻滞剂使用推荐受挑战, objectType=article, longId=31306, objectId=f9ea3130654, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9ea3130654, replyNumber=0, likeNumber=68, createdTime=2014-03-01, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9ea3130654, moduleTitle=Lancet：欧洲心脏病学会β受体阻滞剂使用推荐受挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9ea3130654)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274921, encodeId=cd7c12e492121, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=孙宁玲：如何看待“JNC 8”对β受体阻滞剂的不同意见？, objectType=article, longId=28804, objectId=48aa2880427, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48aa2880427, replyNumber=0, likeNumber=67, createdTime=2014-01-04, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48aa2880427, moduleTitle=孙宁玲：如何看待“JNC 8”对β受体阻滞剂的不同意见？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48aa2880427)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274920, encodeId=316f12e4920f2, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=黄峻：JNC8不能否认β受体阻滞剂的“中国特色”, objectType=article, longId=28725, objectId=acd428e2528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acd428e2528, replyNumber=0, likeNumber=59, createdTime=2014-01-01, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acd428e2528, moduleTitle=黄峻：JNC8不能否认β受体阻滞剂的“中国特色”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acd428e2528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274919, encodeId=586512e49196e, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=Chest：荟萃分析显示哮喘患者可有选择地使用β受体阻滞剂, objectType=article, longId=28410, objectId=52282841047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52282841047, replyNumber=0, likeNumber=60, createdTime=2013-12-22, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52282841047, moduleTitle=Chest：荟萃分析显示哮喘患者可有选择地使用β受体阻滞剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52282841047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1274918, encodeId=d2f212e491835, content=<a href='/topic/show?id=338c19228b0' target=_blank style='color:#2F92EE;'>#β受体阻滞剂#</a>, objectTitle=JAMA Intern Med：行非心脏手术的缺血性心脏病患者应用β受体阻滞剂的疗效, objectType=article, longId=27315, objectId=c61a2e315da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c61a2e315da, replyNumber=0, likeNumber=57, createdTime=2013-12-01, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c61a2e315da, moduleTitle=JAMA Intern Med：行非心脏手术的缺血性心脏病患者应用β受体阻滞剂的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c61a2e315da)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

β受体阻滞剂

2020-05-29

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Sci Rep：终末期肾脏疾病患者可应用β受体阻滞剂预防房颤发生

2015-12-30

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Thorax：长效β受体阻滞剂与长效毒蕈碱受体拮抗剂联合治疗COPD的疗效与安全分析

2015-11-10

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

心衰伴房颤患者，β受体阻滞剂仍是治疗的“基石”吗？

2015-11-05

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

非心脏手术患者的高血压治疗无需β受体阻滞剂？

2015-10-17

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JAMA Intern Med：使用β受体阻滞剂降压治疗风险大

2015-10-11

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JACC：急性心肌梗死后β受体阻滞剂的剂量对生存率的影响

2015-09-24

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

BMJ:β受体阻滞剂可减少COPD的急性发作

2015-08-30

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

World J Surg：闭合性创伤性脑损伤后，β受体阻滞剂对生存率的影响

2015-08-19

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JACC Heart Fail：急性失代偿性心衰(ADHF)患者β受体阻滞剂治疗不能停

2015-08-12

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Circulation：冠脉搭桥手术后的病人长期服用β受体阻滞剂有无必要？

2015-05-20

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

SC-ICC2015：孙宁玲--β受体阻滞剂可作为高血压一线治疗药物吗？

2015-04-17

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

CCQO：β受体阻滞剂对冠心病患者没有明显临床疗效

2014-10-11

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

郭艺芳：β受体阻滞剂不会走下神坛

2014-07-17

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JAMA Inter Med：研究质疑心脏搭桥手术前使用β受体阻滞剂的作用

2014-06-19

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Gastroenterology：非选择性β受体阻滞剂可能增加自发性细菌性腹膜炎的肝硬化患者的死亡风险

2014-06-10

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Lancet：欧洲心脏病学会β受体阻滞剂使用推荐受挑战

2014-03-01

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

孙宁玲：如何看待“JNC 8”对β受体阻滞剂的不同意见？

2014-01-04

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

黄峻：JNC8不能否认β受体阻滞剂的“中国特色”

2014-01-01

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

Chest：荟萃分析显示哮喘患者可有选择地使用β受体阻滞剂

2013-12-22

muzishouyi (审核中...)

前往app查看评论内容

#β受体阻滞剂#

JAMA Intern Med：行非心脏手术的缺血性心脏病患者应用β受体阻滞剂的疗效

2013-12-01

科室
- - 订阅+
  - 更多科室
工具
服务